Medication Overuse Headache Successfully Treated by Three Types of Japanese Herbal Kampo Medicine.

alternative therapy goreisan (tj-17) goshuyuto (tj-31) kakkonto (tj-1) kampo medicine (japanese herbal medicine) medication overuse headache (moh) primary headache

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2021
Historique:
accepted: 31 07 2021
entrez: 13 9 2021
pubmed: 14 9 2021
medline: 14 9 2021
Statut: epublish

Résumé

Medication overuse headache (MOH) usually resolves after the overuse is stopped and starting prophylactic medications. However, it can be challenging to prescribe common prophylactic medications when patients have a history of side effects. As an alternative therapy, traditional Japanese herbal kampo medicine can be used. We herein report a case of a MOH woman with a history of side effects by such common prophylactic medications. A 50-year-old woman presented with a severe migraine attack. She had suffered from migraines for 10 years. She had taken loxoprofen and sumatriptan every day for over eight years. As prophylactic medications, lomerizine, valproic acid, and amitriptyline had been prescribed in the past, but they were discontinued due to side effects. Therefore, she could continue only propranolol as prophylactic medication. She had severe pulsatile headaches and nausea every day. We diagnosed triptan- and non-steroidal anti-inflammatory drug-overuse headache (the International Classification of Headache Disorders 3rd edition code 8.2.2 and 8.2.3.2) and chronic migraine (code 1.3). She was admitted and stopped loxoprofen and sumatriptan. We prescribed three types of Japanese herbal kampo medicines - kakkonto (TJ-1), goreisan (TJ-17), and goshuyuto (TJ-31). Her headache was relieved on day 5, and she was discharged on day 7. In the 40 days after discharge, she had only three times mild headaches with a numeric rating scale (NRS) of 2/10. She did not need any triptans nor anti-inflammatory drugs. We herein presented the MOH woman who was successfully treated using three types of kampo medicine. We should pay attention to their side effects, but kampo medicine may be useful for MOH treatment as acute and prophylactic medications for primary headaches.

Identifiants

pubmed: 34513406
doi: 10.7759/cureus.16800
pmc: PMC8405851
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e16800

Informations de copyright

Copyright © 2021, Katsuki et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Curr Med Res Opin. 2006 Aug;22(8):1587-97
pubmed: 16870083
Biol Pharm Bull. 2009 Feb;32(2):237-41
pubmed: 19182382
J Pharmacol Sci. 2008 Sep;108(1):89-94
pubmed: 18776713
Pain Rep. 2017 Jul 26;2(4):e612
pubmed: 29392227
Intern Med. 2020 Jan 1;59(1):55-60
pubmed: 31484905
Intern Med. 2022 Jan 1;61(1):29-35
pubmed: 33551404
Surg Neurol Int. 2020 Dec 29;11:475
pubmed: 33500813
J Gen Fam Med. 2019 Apr 03;20(3):118-121
pubmed: 31065478
Biochem Biophys Res Commun. 2014 Jun 13;448(4):355-60
pubmed: 24747567
J Stroke Cerebrovasc Dis. 2018 Mar;27(3):758-763
pubmed: 29153303
Int Sch Res Notices. 2016 Oct 13;2016:9351787
pubmed: 27819025

Auteurs

Masahito Katsuki (M)

Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, JPN.

Shin Kawamura (S)

Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, JPN.

Kenta Kashiwagi (K)

Department of Neurology, Itoigawa General Hospital, Itoigawa, JPN.

Akihito Koh (A)

Department of Neurosurgery, Itoigawa General Hospital, Itoigawa, JPN.

Classifications MeSH